Plexus (NASDAQ:PLXS) CEO Sells $358,740.00 in Stock

Plexus Corp. (NASDAQ:PLXS) CEO Todd Kelsey sold 1,500 shares of the company’s stock in a transaction dated Wednesday, October 21st. The stock was sold at an average price of $239.16, for a total value of $358,740.00. Following the completion of the transaction, the chief executive officer directly owned 62,888 shares of the company’s stock, valued at approximately $15,040,294.08. This trade represents a 2.33% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Plexus Price Performance

Shares of NASDAQ:PLXS traded down $17.93 during trading on Thursday, hitting $220.78. 439,666 shares of the company’s stock were exchanged, compared to its average volume of 310,960. Plexus Corp. has a 52-week low of $132.03 and a 52-week high of $307.06. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.49 and a quick ratio of 0.72. The company has a market cap of $5.91 billion, a price-to-earnings ratio of 32.56 and a beta of 0.88. The business’s 50-day simple moving average is $251.49 and its 200 day simple moving average is $258.52.

Plexus (NASDAQ:PLXS) last announced its quarterly earnings data on Wednesday, July 29th. The technology company reported $2.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.13 by $0.19. The business had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.23 billion. Plexus had a net margin of 4.03% and a return on equity of 12.46%. The company’s revenue was up 28.2% on a year-over-year basis. During the same period last year, the firm posted $1.64 EPS. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. As a group, equities analysts predict that Plexus Corp. will post 7.13 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts recently weighed in on PLXS shares. Sidoti raised shares of Plexus from a “neutral” rating to a “buy” rating and set a $308.00 target price for the company in a research note on Friday, July 31st. Weiss Ratings upgraded shares of Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Wall Street Zen upgraded shares of Plexus from a “hold” rating to a “buy” rating in a research note on Sunday, October 4th. KeyCorp raised shares of Plexus from a “sector weight” rating to an “overweight” rating and set a $300.00 price objective for the company in a report on Monday, September 21st. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $310.00 target price on shares of Plexus in a report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating and seven have assigned a Buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $276.86.

Hedge Funds Weigh In On Plexus

Institutional investors have recently bought and sold shares of the business. BlackRock Inc. purchased a new position in shares of Plexus in the 2nd quarter worth $1,311,631,000. Congress Asset Management Co. raised its position in shares of Plexus by 204.0% during the 3rd quarter. Congress Asset Management Co. now owns 315,396 shares of the technology company’s stock valued at $82,303,000 after buying an additional 211,663 shares in the last quarter. Bank of America Corp DE bought a new position in shares of Plexus in the 2nd quarter valued at about $60,281,000. Bank of New York Mellon Corp bought a new position in shares of Plexus in the 2nd quarter valued at about $55,525,000. Finally, Emerald Advisers LLC bought a new position in shares of Plexus in the 1st quarter valued at about $33,729,000. Institutional investors own 94.45% of the company’s stock.

About Plexus

Plexus Corp. is an electronics manufacturing services company that helps customers design, develop, manufacture and service complex electronic products. The company provides an integrated product-realization process spanning engineering and design, supply-chain management, manufacturing, testing, logistics and aftermarket services.

Plexus supports original equipment manufacturers in industries including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications.